European Medical Market Access Network (EUMMAN) has invited BioPortUSA to present a webinar on market entry USA to their clients on Monday, June 8th, 2020. Mark Lesselroth, CEO of BioPort will talk about what it takes to be successful in the U.S. Healthcare market and what steps one should take before considering entering the market.[...]
BioPortUSA has been invited to present to a group of Danish medtech start-ups on Thursday, May 21st on market entry USA. The focal point will be on how these companies can access the market efficiently and successfully by reviewing a step-process BioPort has developed.[...]
Teicos Pharma (www.teicospharma.com) is a Finish based Pharmaceutical Start-Up whose business is the production and sales of a new class of inhalable API (active pharmaceutical ingredient) powders for dry powder Inhalers (DPI). [...]
BioPortUSA announced today that they have started work with French based Fizimed “We are excited to be working with Fizimed, our first women founded and women owned life sciences client” said Mark Lesselroth, CEO of Bioport.[...]
BioPortUSA is excited to announce that it was recently engaged by Thornhill Medical (www.thornhillmedical.com), to conduct a market landscape for their ClearMate product.[...]
BioPortUSA is excited to announce the addition of Dr. Karsten Risch to our Board of Advisors. Dr. Risch brings a unique skill set as Chief Medical officer for Evoke, a global life science marketing communications firm. [...]
BioPortUSA announced a new partnership with GloriMed Consulting (http://www.glorimed.fr/), a leading French provider of Regulatory Affairs, Development, Marketing and communications for the medical device industry.[...]
BioPortUSA announced a new partnership with GlobalMedHub a leading Middle East medtech consultancy based out of Dubai. GMH is strategically positioned to help international medtech companies from Europe and the U.S.A. to gain access to a challenging market.[...]
Social Media
